Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Lotus Eye Hospital & Institute Days Payable?
Lotus Eye Hospital & InstituteBOM:532998 +0.16%62 Days Payable is 42.75 as of Mar. 2026, which is 27% below its 10-year median of 58.50. GuruFocus rates BOM:532998 with a GF Score™ of 62/100 and a GF Value™ of ₹92.14 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks worse than 62.27% on this metric.
The historical rank and industry rank for Lotus Eye Hospital & Institute's Days Payable or its related term are showing as below:
BOM:532998'
s Days Payable Range Over the Past 10 Years
Min: 42.36 Med: 58.5 Max: 67.71
Current: 42.36
During the past 13 years, Lotus Eye Hospital & Institute's highest Days Payable was 67.71. The lowest was 42.36. And the median was 58.50.
BOM:532998's Days Payable is ranked worse than 62.27% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs BOM:532998: 42.36
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532998 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Eye Hospital & Institute Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Days Payable distribution charts can be found below:
* The bar in red indicates where Lotus Eye Hospital & Institute's Days Payable falls into.
Lotus Eye Hospital & Institute Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Eye Hospital & Institute (BOM:532998) has a Days Payable of 42.75 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lotus Eye Hospital & Institute and its competitors. This is 27% below median its historical median of 58.50. Over the past decade, Lotus Eye Hospital & Institute's Days Payable has ranged from 42.36 to 67.71. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #378 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 62.3%.
Is Lotus Eye Hospital & Institute's Days Payable too high?
Lotus Eye Hospital & Institute's current Days Payable of 42.75 is 27% below median its 10-year median of 58.50. Over the past 10 years, this metric has ranged from a low of 42.36 to a high of 67.71. The Healthcare Providers & Services industry median Days Payable is 57.13. Lotus Eye Hospital & Institute's value of 42.75 is 25.2% below this industry median. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #378 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #378 out of 607 companies for Days Payable. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median Days Payable is 57.13. Lotus Eye Hospital & Institute's value of 42.75 is 25.2% below this benchmark. Historically, Lotus Eye Hospital & Institute's own Days Payable has ranged from 42.36 to 67.71 over the past decade. While the company's 10-year median is 58.50 vs. the industry median of 57.13, Lotus Eye Hospital & Institute has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Eye Hospital & Institute's current Days Payable of 42.75 is 25.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current Days Payable is 42.75, which is 27% below median its own 10-year median of 58.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹92.14, compared to a current price of ₹121.90 — trading 32.3% above its estimated fair value. The current Days Payable is 42.75, which is 27% below median its 10-year median of 58.50 and 25.2% below the Healthcare Providers & Services industry median of 57.13. Lotus Eye Hospital & Institute's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Days Payable is 42.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued.
The current stock price of ₹121.90 is trading 32.3% above its estimated GF Value™ of ₹92.14.
GuruFocus considers Lotus Eye Hospital & Institute to be Significantly Overvalued.
Key valuation signals for BOM:532998:
Days Payable: 42.75 (27% below median its 10-year median of 58.50)
GF Value™: ₹92.14 vs. price of ₹121.90 (32.3% above fair value)
Industry Position: 25.2% below the Healthcare Providers & Services median (#378 of 607)
No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Eye Hospital & Institute Business Description
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
62GF Score
Get the complete analysis for BOM:532998
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532998 has been successfully added to your 
